Denmark Chemicals

Novozymes A/S (NSIS-B)

Track

Track

Novozymes A/S experienced significant insider trading activity recently, characterized by substantial divestments from key executives. Following the latest results financiers, leadership members including the Chief Operating Officer offloaded shares worth over 54 million DKK. These transactions represent a notable shift in sentiment among senior management regarding the current equity valuation.
Ticker: NSIS-B Exchange: CPH
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Novozymes A/S. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Anders Lund Chief Operating Officer Officer
Transaction date
Sale
Price
465.01
Quantity 88,497
Value DKK1,298,672
Anders Lund Chief Operating Officer Officer
Transaction date
Sale
Price
439.00
Quantity 67,048
Value DKK4,592,372
2.3
Tina Sejersgård Fanø Executive Vice President, Planetary Health Biosolutions Officer
Transaction date
Sale
Price
292.29
Quantity 13,410
Value DKK4,723,547
Henrik Jørck Nielsen Executive Vice President, Human Health Biosolutions & Strategy Officer
Transaction date
Sale
Price
446.12
Quantity 12,500
Value DKK5,576,538
2.9
Heine Dalsgaard Vice Chair of the Board Director
Transaction date
Purchase
Price
393.69
Quantity 2,500
Value DKK984,229
0.9
Claus Crone Fuglsang Executive Vice President, Chief Scientific Officer Officer
Transaction date
Sale
Price
372.18
Quantity 6,269
Value DKK2,333,173
3.2
Morten Enggaard Rasmussen Executive Vice President, People & Stakeholder Relations Officer
Transaction date
Purchase
Price
344.40
Quantity 375
Value DKK129,150
3.2
Morten Enggaard Rasmussen Executive Vice President, People & Stakeholder Relations Officer
Transaction date
Purchase
Price
347.40
Quantity 725
Value DKK251,865
2.9
Kevin Lane Member of the Board Director
Transaction date
Purchase
Price
368.10
Quantity 1,500
Value DKK552,150
2.9
Heine Dalsgaard Vice Chair of the Board Director
Transaction date
Purchase
Price
371.98
Quantity 2,700
Value DKK1,004,347
2.9
Heine Dalsgaard Vice Chair of the Board Director
Transaction date
Purchase
Price
397.07
Quantity 2,500
Value DKK992,679
3.2
Morten Enggaard Rasmussen Executive Vice President of People & Stakeholder Relations Officer
Transaction date
Purchase
Price
418.10
Quantity 380
Value DKK158,878
2.3
Tina Sejersgård Fanø Executive Vice President, Planetary Health Biosolutions Officer
Transaction date
Sale
Price
405.46
Quantity 48,610
Value DKK19,709,251
3.6
Rainer Lehmann CFO & Executive Vice President Officer
Transaction date
Purchase
Price
396.23
Quantity 2,000
Value DKK792,458
2.9
Heine Dalsgaard Vice Chair of the Board of Directors Executive Director
Transaction date
Purchase
Price
398.49
Quantity 3,000
Value DKK1,195,470
3.2
Morten Enggaard Rasmussen Executive Vice President of People & Stakeholder Relations Officer
Transaction date
Purchase
Price
390.00
Quantity 716
Value DKK279,240
3.6
Rainer Lehmann CFO & Executive Vice President Officer
Transaction date
Purchase
Price
396.23
Quantity 2,000
Value DKK792,458
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-25 2026-08-24 S Sale
Anders Lund

Chief Operating Officer

Officer
88,497
465.01
DKK1,298,672 		88,497 465.01 DKK1,298,672
2026-08-25 2026-08-21 S Sale
Anders Lund

Chief Operating Officer

Officer
67,048
439.00
DKK4,592,372 		67,048 439.00 DKK4,592,372
2026-08-25 2026-08-21 S Sale
2.3
Tina Sejersgård Fanø

Executive Vice President, Planetary Health Biosolutions

Officer
13,410
292.29
DKK4,723,547 		13,410 292.29 DKK4,723,547
2026-08-25 2026-08-21 S Sale
Henrik Jørck Nielsen

Executive Vice President, Human Health Biosolutions & Strategy

Officer
12,500
446.12
DKK5,576,538 		12,500 446.12 DKK5,576,538
2026-05-06 2026-05-06 B Purchase
2.9
Heine Dalsgaard

Vice Chair of the Board

Director
2,500
393.69
DKK984,229 		2,500 393.69 DKK984,229
2026-03-26 2026-03-25 S Sale
0.9
Claus Crone Fuglsang

Executive Vice President, Chief Scientific Officer

Officer
6,269
372.18
DKK2,333,173 		6,269 372.18 DKK2,333,173
2026-03-23 2026-03-19 B Purchase
3.2
Morten Enggaard Rasmussen

Executive Vice President, People & Stakeholder Relations

Officer
375
344.40
DKK129,150 		375 344.40 DKK129,150
2026-03-11 2026-03-11 B Purchase
3.2
Morten Enggaard Rasmussen

Executive Vice President, People & Stakeholder Relations

Officer
725
347.40
DKK251,865 		725 347.40 DKK251,865
2026-02-27 2026-02-26 B Purchase
2.9
Kevin Lane

Member of the Board

Director
1,500
368.10
DKK552,150 		1,500 368.10 DKK552,150
2026-02-26 2026-02-26 B Purchase
2.9
Heine Dalsgaard

Vice Chair of the Board

Director
2,700
371.98
DKK1,004,347 		2,700 371.98 DKK1,004,347
2025-11-21 2025-11-20 B Purchase
2.9
Heine Dalsgaard

Vice Chair of the Board

Director
2,500
397.07
DKK992,679 		2,500 397.07 DKK992,679
2025-11-07 2025-11-07 B Purchase
3.2
Morten Enggaard Rasmussen

Executive Vice President of People & Stakeholder Relations

Officer
380
418.10
DKK158,878 		380 418.10 DKK158,878
2025-09-02 2025-09-01 S Sale
2.3
Tina Sejersgård Fanø

Executive Vice President, Planetary Health Biosolutions

Officer
48,610
405.46
DKK19,709,251 		48,610 405.46 DKK19,709,251
2025-08-28 2025-08-25 B Purchase
3.6
Rainer Lehmann

CFO & Executive Vice President

Officer
2,000
396.23
DKK792,458 		2,000 396.23 DKK792,458
2025-08-22 2025-08-22 B Purchase
2.9
Heine Dalsgaard

Vice Chair of the Board of Directors

Executive Director
3,000
398.49
DKK1,195,470 		3,000 398.49 DKK1,195,470
2025-08-22 2025-08-22 B Purchase
3.2
Morten Enggaard Rasmussen

Executive Vice President of People & Stakeholder Relations

Officer
716
390.00
DKK279,240 		716 390.00 DKK279,240
2025-08-28 2025-02-25 B Purchase
3.6
Rainer Lehmann

CFO & Executive Vice President

Officer
2,000
396.23
DKK792,458 		2,000 396.23 DKK792,458
Explore more

More insider trading research around Novozymes A/S

More insider trades in Denmark
Similar Basic Materials companies with insider activity
More Chemicals companies with insider activity
More Chemicals companies with insider activity
Insider trading in Europe
Insider trades in Europe Stoxx 600